Emmaus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1	1	1	6	13	82
Market Cap Growth	-67.97%	52.94%	-91.23%	-52.02%	-84.34%	36.67%
Enterprise Value	32	32	32	39	42	103
Last Close Price	0.01	0.01	0.01	0.10	0.26	1.67
Forward PE	-	-	-	-	4.34	-
PS Ratio	0.06	0.07	0.03	0.21	0.70	4.00
PB Ratio	-0.01	-0.01	-0.01	-0.13	-0.38	-3.84
EV/Sales Ratio	2.63	2.59	1.91	1.31	2.27	4.99
EV/EBITDA Ratio	33.73	119.35	-	10.85	-	-
EV/EBIT Ratio	81.45	139.50	-	10.95	-	-
Debt / Equity Ratio	-0.47	-0.51	-0.58	-0.70	-0.90	-1.04
Debt / EBITDA Ratio	34.11	42.28	-	7.05	-	-
Net Debt / Equity Ratio	-0.45	-0.48	-0.56	-0.65	-0.84	-0.94
Net Debt / EBITDA Ratio	70.68	112.71	-16.87	8.64	-4.41	-3.32
Net Debt / FCF Ratio	-48.64	-2536.00	-13.74	-20.31	-5.65	-15.17
Asset Turnover	0.58	0.55	0.57	0.71	0.35	0.36
Inventory Turnover	0.48	0.54	0.72	0.66	0.76	0.58
Quick Ratio	0.04	0.07	0.06	0.13	0.04	0.09
Current Ratio	0.09	0.11	0.11	0.19	0.12	0.25
Return on Assets (ROA)	1.18%	0.64%	-4.03%	5.31%	-7.84%	-6.59%
Return on Capital Employed (ROCE)	-0.70%	-0.50%	4.70%	-13.40%	108.00%	-31.20%
Earnings Yield	-1186.86%	-902.38%	-1188.71%	-60.31%	-82.36%	-19.36%
FCF Yield	-88.70%	-1.44%	-423.32%	-24.56%	-39.53%	-1.61%
Buyback Yield / Dilution	-2.95%	-1.27%	-19.07%	-7.41%	-0.38%	-0.73%